Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Enanta Pharmaceuticals Inc. buy Westpark Capital

Enanta Pharmaceuticals Inc.
Start price
€10.60
30.09.25 / 50%
Target price
€23.89
30.09.26
Performance (%)
8.49%
Price
€11.50
18.08.26
Summary
This prediction is currently active. With a performance of 8.49%, the BUY prediction by Westpark_Capital for Enanta Pharmaceuticals Inc. is trending in the right direction. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Enanta Pharmaceuticals Inc. -6.897% -6.897%
iShares Core DAX® -0.874% 5.325%
iShares Nasdaq 100 -0.381% 1.979%
iShares Nikkei 225® -1.676% 1.952%
iShares S&P 500 -0.655% 2.069%

Comments by Westpark_Capital for this prediction

In the thread Enanta Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 8.49%
Target price 23.890
Change
Ends at 30.09.26

Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat

Westpark Capital 
0
Report Share
30.09.25

Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.

buy
Enanta Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.60
02.09.25
€20.51
02.09.26
51.32%
18.08.26

Westpark Capital 
02.09.25 50%